In “Acknowledgments” on page 2296 of the 22 November 2018 issue, support from the Deutsche Forschungsgemeinschaft for Martina U. Muckenthaler (grants SFB1036 and SFB1118) is not acknowledged. The error has been corrected in the online version.
. 2019 May 14;134(1):94. doi: 10.1182/blood.2019001583
Artuso I, Lidonnici MR, Altamura S, et al. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model. Blood. 2018;132(21):2286-2297.
Received 2019 May 13; Accepted 2019 May 13; Issue date 2019 Jul 4.
© 2019 by The American Society of Hematology
PMCID: PMC6911818 PMID: 31273007
This corrects the article "Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model" in volume 132 on page 2286.